Investors in Hims & Hers Health Inc. urged to act by November 2
News provided byHims & Hers Health, Inc · 2 min read
NEW YORK, Faruqi & Faruqi, LLP, a leading national securities law firm, has reminded investors in Hims & Hers Health, Inc. (HIMS) of an important deadline as they investigate potential claims against the company. Investors who purchased Hims securities between August 4, 2025, and July 29, 2026, are encouraged to contact the firm to discuss their legal rights.
On July 29, 2026, the Federal Trade Commission (FTC) filed a lawsuit against Hims, alleging that the company shared consumers' sensitive health information with third-party advertising platforms, despite claiming to maintain consumer privacy. The FTC's announcement, along with the subsequent drop in Hims' stock price, triggered a series of events that may impact investors.
According to the complaint, Hims and its executives violated federal securities laws by making false and misleading statements, or failing to disclose material information. Specifically, the lawsuit alleges that the company shared consumer data with third-party platforms, charged consumers for prescriptions almost immediately after submitting intake forms, despite promising a consultation with a medical provider, and faced regulatory scrutiny as a result.
On the same day, Hims' stock price fell $4.32, or 14.73%, to close at $25.00 per share on unusually heavy trading volume. This sudden drop in stock price and volume highlighted the potential impact of the FTC's allegations on investor confidence.
Faruqi & Faruqi, LLP, which has recovered hundreds of millions of dollars for investors since its founding in 1995, is now seeking to represent investors in a federal securities class action. The firm is reminding investors that they have until November 2, 2026, to seek the role of lead plaintiff.
Josh Wilson, a partner at Faruqi & Faruqi, encourages investors to contact the firm directly at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their legal rights and potential claims. The firm has also urged anyone with relevant information about Hims' conduct to come forward.
Investors who purchased or otherwise acquired Hims securities during the defined period are eligible to participate in the lawsuit. To be considered, they must file a motion with the court no later than November 2, 2026. However, participation does not require seeking appointment as lead plaintiff, as any investor who purchased Hims securities during the Class Period may be a class member.
If you have any questions about your eligibility or the lead plaintiff process, it is recommended that you consult with legal counsel.